Last reviewed: May 30, 2026

Last updated: May 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, GLP-1 medication shortages have largely resolved as of 2024, expanding patient access to multiple formulations and dosing options. Supply chain normalization, combined with new compounded alternatives and branded products, has created a more diverse treatment ecosystem requiring informed decision-making.

This expanded landscape makes personalization increasingly important. Understanding your baseline biomarkers and genetic context in peptide metabolism can help support conversations with your provider about which GLP-1 approach may align best with your individual physiology and health goals.

How GLP-1 Supply Has Stabilized Since 2023

In 2023, demand for semaglutide and tirzepatide far exceeded supply due to unexpected adoption for weight management beyond diabetes. FDA manufacturing coordination, expanded production capacity, and regulatory approval of compounded alternatives significantly improved availability by late 2023 through 2024.

Current supply includes branded injectables (Ozempic, Mounjaro), oral formulations (Rybelsus, Zepbound), and compounded options from licensed 503A pharmacies. This multi-pathway availability means patients now have realistic access but must evaluate options based on medical history, preferences, and clinical evidence rather than availability alone.

The Compounded vs. Branded Treatment Framework

Both compounded and branded GLP-1 medications work through similar mechanisms but differ in manufacturing oversight, cost, and customization. Understanding these distinctions supports informed provider conversations about which pathway aligns with your clinical needs and circumstances.

Treatment Path Key Characteristics Cost Range (Typical) Clinical Context
Compounded Semaglutide From licensed 503A pharmacy; dosing flexibility; lower cost $179–$229/month For patients prioritizing cost, customized dosing, or who cannot access branded options
Compounded Tirzepatide Dual GLP-1/GIP mechanism; 503A pharmacy; customizable strength $229–$309/month For those exploring dual-mechanism peptide therapy; may offer different metabolic profile
Branded Semaglutide (Wegovy/Ozempic) FDA-approved; standardized dosing; established safety database $900–$1,300/month retail For patients with insurance coverage or who prefer established branded formulations
Branded Tirzepatide (Zepbound/Mounjaro) FDA-approved dual mechanism; fixed dosing; extensive clinical trials $700–$1,200/month retail For those exploring GLP-1/GIP pathway with full regulatory approval history

Genetic Predispositions That Inform Treatment Selection

Emerging research suggests certain genetic variants in GLP-1 receptor, GIPR, FTO, and MC4R pathways may correlate with metabolic responses. While no genetic test predicts exact medication response, understanding your predispositions in these peptide pathways can contextualize provider discussions about whether GLP-1 therapy aligns with your individual biology.

PlexusDx Precision Peptide Genetic Test examines key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313. These predispositions may help clarify whether you carry genetic markers associated with stronger GLP-1 pathway sensitivity, informing more targeted treatment conversations with your provider.

Safety, Eligibility, and Provider-Guided Decision-Making

GLP-1 medications are not appropriate for everyone. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, active pancreatitis, severe diabetic retinopathy, and certain pregnancy circumstances. A qualified healthcare provider must evaluate your complete medical history before recommending any formulation.

The expanded treatment landscape requires thoughtful provider partnership. Discussing your baseline metabolic biomarkers, genetic context, medication history, and health goals helps your provider select the formulation and dose most likely to be effective and tolerable for your specific situation. Neither genetic predisposition nor availability alone should drive treatment selection.

How PlexusDx Supports a More Personalized Approach

PlexusDx recognizes that GLP-1 treatment success depends not only on medication availability but also on alignment between the chosen formulation and your individual metabolic pathway. Our Precision Peptide Genetic Test may help provide context about your predispositions in key peptide signaling genes, supporting more informed discussions with your provider about which GLP-1 approach may be most suitable for your physiology.

The Precision Peptide Genetic Test reveals predispositions in GIPR, GLP1R, FTO, and MC4R pathways—genes that influence how your body responds to GLP-1 and GIP signaling. This information should be interpreted with a qualified healthcare provider, as genetic predisposition does not guarantee medication response or outcome. Instead, it adds a layer of personalization to the clinical conversation.

By combining genetic insights with biomarker assessment and medical history, you and your provider can make more targeted decisions about whether compounded semaglutide, compounded tirzepatide, or another GLP-1 pathway is most aligned with your health needs. This precision-wellness approach transforms the expanded treatment landscape from overwhelming choice into informed personalization.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $229-$309/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves